Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
14/06/202402:40Alliance NewsAlliance NewsTOP NEWS: Tesco backs outlook after strong UK sales in first quarterLSE:TSCOTesco Plc
14/06/202402:40GlobeNewswire Inc.Form 8.5 (EPT/RI) - FireAngel Safety Technology Group Plc
14/06/202402:34PR Newswire (US)Yiren Digital to Report First Quarter 2024 Financial Results on June 21, 2024NYSE:YRDYiren Digital Ltd
14/06/202402:32GlobeNewswire Inc.Une tournée internationale des médias à Jinan, pour découvrir le charme unique de la ville des sources
14/06/202402:17PR Newswire (US)Introducing ZW3D 2025: Embark on a Seamless Journey from Design to Manufacturing
14/06/202402:17PR Newswire (US)Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
14/06/202402:15NEWSBTCCardano Price Drops As Hoskinson Clarifies Relationship To Elon MuskCOIN:DOGEUSDDogecoin
14/06/202402:15GlobeNewswire Inc.HSBC Bank plc: Post Stabilisation Notice
14/06/202402:11GlobeNewswire Inc.Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging Market Interest
14/06/202402:06GlobeNewswire Inc.Nikkiso Clean Energy & Industrial Gases Group anuncia transición de director ejecutivo para el día 1ro. de julio de 2024
14/06/202402:06GlobeNewswire Inc.Nikkiso Clean Energy & Industrial Gases Group Anuncia Transição de CEO para o dia 1º de julho de 2024
14/06/202402:06GlobeNewswire Inc.Le groupe Nikkiso Clean Energy & Industrial Gases annonce un changement de direction au 1er juillet 2024
14/06/202402:06GlobeNewswire Inc.Nikkiso Clean Energy & Industrial Gases Group kündigt Wechsel des CEO zum 1. Juli 2024 an
14/06/202402:05GlobeNewswire Inc.Zefiro Publishes “Letter from the CEO” Following its Inaugural Earnings ReportNEO:ZEFIZefiro Methane Corp
14/06/202402:05PR Newswire (US)Rigel Announces Five Presentations at the EHA2024 Hybrid CongressNASDAQ:RIGLRigel Pharmaceuticals Inc
14/06/202402:04The Daily HodlHere’s What Needs To Happen for Bitcoin To Hit New All-Time Highs, According to Fidelity Analyst Jurrien TimmerCOIN:BTCUSDBitcoin
14/06/202402:03Business WireVertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) CongressNASDAQ:VRTXVertex Pharmaceuticals Inc
14/06/202402:02GlobeNewswire Inc.Flash News: OKX Announces Exclusive Minting of Slerf NFTs on its Marketplace
14/06/202402:01PR Newswire (US)The Safavi Impact Institute Sponsors NASA's Space Center Houston's pilot education program in Austria
14/06/202402:01PR Newswire (US)MSC Cruises launches first Tea Library at sea to create perfect cuppa from home for Brits
14/06/202402:01GlobeNewswire Inc.Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
14/06/202402:00Business WireELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple MyelomaNYSE:PFEPfizer Inc
14/06/202402:00GlobeNewswire Inc.Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell DiseaseNASDAQ:BEAMBeam Therapeutics Inc
14/06/202402:00GlobeNewswire Inc.Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
14/06/202402:00Business WireImmune-Onc Therapeutics to Present Additional Positive Interim Data from IO-202 Phase 1b Expansion Cohort in Patients with Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Association (EHA) Annual Congress
14/06/202402:00Business WireNew Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of TreatmentNASDAQ:GILDGilead Sciences Inc
14/06/202402:00GlobeNewswire Inc.Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024
14/06/202402:00PR Newswire (US)Brickken is selected to participate in the European Blockchain Regulatory Sandbox
14/06/202402:00PR Newswire (US)Top tips for retail store remodeling from the Paso Robles general contractor
14/06/202402:00PR Newswire (US)Protecting the vulnerable--Atascadero estate planning attorney on guardianships and conservatorships